WebAbout BioMS Medical Corp. BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical’s lead technology, dirucotide, is for the treatment of multiple sclerosis. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and ... WebDec 18, 2007 · INDIANAPOLIS and EDMONTON, Alberta, Dec. 17 /PRNewswire-FirstCall/ -- Eli Lilly and Company and BioMS Medical Corp. today announced that the two …
BioMS Medical Corp. - Company Profile - BCIQ
WebAbout BioMS Medical Corp. ----- BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive ... WebMay 3, 2010 · BioMS Medical also announced it intends to change its name to Medwell Capital Corp. subject to approval by the Toronto Stock Exchange and shareholders at the annual general meeting to be held on ... flowers by brianna joy
Fawn Creek, KS Map & Directions - MapQuest
WebKey Findings Provides intelligence on Medwell Capital Corp. formerly BioMS Medical Corp. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Medwell Capital Corp. formerly BioMS Medical Corp. and its subsidiaries since 2007. WebDec 19, 2007 · Shares of BioMS Medical Corp. jumped 38 percent Tuesday after the company unveiled plans to license its Phase III multiple sclerosis drug MBP8298 to Eli … WebJun 20, 2008 · A successful phase II trial of BioMS Medical Corp.'s lead compound dirucotide for the treatment of Multiple Sclerosis would undoubtedly give a boost to the biotech share price, but with results ... flowers by brandi milford ohio